Alnylam Pharma Names Manmeet Soni as New CFO

Shares of Alnylam Pharmaceuticals were 3% higher Tuesday morning after the biopharmaceutical firm said it named Manmeet S. Soni as its CFO. Michael Mason, vice president, finance and treasurer, who had assumed the responsibilities as principal financial officer on Jan. 6, will relinquish these responsibilities upon the effectiveness of Soni’s appointment. Mason will continue to serve as the vice president, finance and treasurer and as principal accounting officer.

Soni most recently served as CFO and treasurer of ARIAD Pharmaceuticals and previously served as CFO and treasurer of Pharmacyclics, which was acquired by AbbVie (ABBV) for $21 billion.

Leave a Comment